The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects
Identifieur interne : 002E98 ( Main/Exploration ); précédent : 002E97; suivant : 002E99The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects
Auteurs : Pierre J. Blanchet [Canada]Source :
- Canadian journal of neurological sciences [ 0317-1671 ] ; 2003.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Animals, Antiparkinson agent, Chemotherapy, Drug Administration Schedule, Dyskinesias (etiology), Dyskinesias (metabolism), Fluctuations, Haplorhini, Human, Humans, Levodopa, Levodopa (administration & dosage), Levodopa (adverse effects), Motricity, Parkinson Disease (drug therapy), Parkinson disease, Pathophysiology, Rats, Receptors, Dopamine (metabolism), Receptors, GABA (metabolism), Receptors, N-Methyl-D-Aspartate (metabolism), Receptors, Neurotransmitter (drug effects), Receptors, Neurotransmitter (metabolism), Receptors, Opioid (metabolism).
- MESH :
- chemical , administration & dosage : Levodopa.
- chemical , adverse effects : Levodopa.
- chemical , drug effects : Receptors, Neurotransmitter.
- drug therapy : Parkinson Disease.
- etiology : Dyskinesias.
- metabolism : Dyskinesias, Receptors, Dopamine, Receptors, GABA, Receptors, N-Methyl-D-Aspartate, Receptors, Neurotransmitter, Receptors, Opioid.
- Animals, Drug Administration Schedule, Haplorhini, Humans, Rats.
Abstract
Le patient parkinsonien fluctuant - Aspects cliniques et physiopathologiques. Les complications motrices associées à la dopathérapie chez le Parkinsonien constituent toujours un défi au plan théorique et thérapeutique mais des progrès majeurs ont été réalisés durant la dernière décennie, favorisant le développement de plusieurs médications prometteuses. Il n'est peut-être pas loin le jour où ces nouveaux agents pourront prévenir, soulager ou même renverser pour de bon ("déprogramme") ces complications fréquentes et handicapantes. Une connaissance des mécanismes fondamentaux à l'origine de cette fascinante conversion dans le cerveau parkinsonien et des hypothèses explorées permet aux neurologues de mieux comprendre la logique entourant les stratégies correctrices en émergence.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000A75
- to stream PascalFrancis, to step Curation: 000248
- to stream PascalFrancis, to step Checkpoint: 000910
- to stream Main, to step Merge: 003296
- to stream PubMed, to step Corpus: 001447
- to stream PubMed, to step Curation: 001447
- to stream PubMed, to step Checkpoint: 001447
- to stream Ncbi, to step Merge: 000293
- to stream Ncbi, to step Curation: 000293
- to stream Ncbi, to step Checkpoint: 000293
- to stream Main, to step Merge: 003133
- to stream Main, to step Curation: 002E98
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects</title>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Stomatology, Faculty of Dentistry, Universite de Montreal, and Andre-Barbeau Movement Disorders Unit, Hôtel-Dieu du CHUM</s1>
<s2>Montreal, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0282002</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0282002 INIST</idno>
<idno type="RBID">Pascal:03-0282002</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A75</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000248</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000910</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000910</idno>
<idno type="wicri:doubleKey">0317-1671:2003:Blanchet P:the:fluctuating:parkinsonian</idno>
<idno type="wicri:Area/Main/Merge">003296</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12691473</idno>
<idno type="wicri:Area/PubMed/Corpus">001447</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001447</idno>
<idno type="wicri:Area/PubMed/Curation">001447</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001447</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001447</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001447</idno>
<idno type="wicri:Area/Ncbi/Merge">000293</idno>
<idno type="wicri:Area/Ncbi/Curation">000293</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000293</idno>
<idno type="wicri:doubleKey">0317-1671:2003:Blanchet P:the:fluctuating:parkinsonian</idno>
<idno type="wicri:Area/Main/Merge">003133</idno>
<idno type="wicri:Area/Main/Curation">002E98</idno>
<idno type="wicri:Area/Main/Exploration">002E98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects</title>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Stomatology, Faculty of Dentistry, Universite de Montreal, and Andre-Barbeau Movement Disorders Unit, Hôtel-Dieu du CHUM</s1>
<s2>Montreal, QC</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Drug Administration Schedule</term>
<term>Dyskinesias (etiology)</term>
<term>Dyskinesias (metabolism)</term>
<term>Fluctuations</term>
<term>Haplorhini</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Motricity</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Pathophysiology</term>
<term>Rats</term>
<term>Receptors, Dopamine (metabolism)</term>
<term>Receptors, GABA (metabolism)</term>
<term>Receptors, N-Methyl-D-Aspartate (metabolism)</term>
<term>Receptors, Neurotransmitter (drug effects)</term>
<term>Receptors, Neurotransmitter (metabolism)</term>
<term>Receptors, Opioid (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Neurotransmitter</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesias</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Dyskinesias</term>
<term>Receptors, Dopamine</term>
<term>Receptors, GABA</term>
<term>Receptors, N-Methyl-D-Aspartate</term>
<term>Receptors, Neurotransmitter</term>
<term>Receptors, Opioid</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Drug Administration Schedule</term>
<term>Haplorhini</term>
<term>Humans</term>
<term>Rats</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Fluctuation</term>
<term>Motricité</term>
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Physiopathologie</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="fr">Le patient parkinsonien fluctuant - Aspects cliniques et physiopathologiques. Les complications motrices associées à la dopathérapie chez le Parkinsonien constituent toujours un défi au plan théorique et thérapeutique mais des progrès majeurs ont été réalisés durant la dernière décennie, favorisant le développement de plusieurs médications prometteuses. Il n'est peut-être pas loin le jour où ces nouveaux agents pourront prévenir, soulager ou même renverser pour de bon ("déprogramme") ces complications fréquentes et handicapantes. Une connaissance des mécanismes fondamentaux à l'origine de cette fascinante conversion dans le cerveau parkinsonien et des hypothèses explorées permet aux neurologues de mieux comprendre la logique entourant les stratégies correctrices en émergence.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:03-0282002 |texte= The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects }}
This area was generated with Dilib version V0.6.29. |